New research reveals posttraumatic stress disorder (PTSD)—a serious and disabling mental disorder—can be treated with intensive daily exposure therapy over two weeks, rather than the typical prolonged weekly exposure ...
Aug 18, 2022
0
39
Newly infected COVID-19 patients have two treatment options that can be taken at home. But that convenience comes with a catch: The pills have to be taken as soon as possible once symptoms appear.
Apr 26, 2022
0
19
Dogs are humans' best friends and it is always distressing for dog owners when their beloved pets contract terminal illnesses. Canine cancer is the leading cause of death in dogs and when they are diagnosed with late-stage ...
Jan 30, 2023
0
17
More than two-thirds of people who have a type of heart attack not caused by a blood clot also may have undiagnosed heart disease, according to a small study from Scotland.
Mar 28, 2022
0
59
(HealthDay)—The addition of subcutaneous tirzepatide versus placebo to titrated insulin glargine results in significant improvements in glycemic control among patients with type 2 diabetes and inadequate glycemic control, ...
Feb 10, 2022
0
2
Two in three Australians will have a skin cancer in their lifetime, nearly all of them basal cell carcinomas (BCC), squamous cell carcinomas (SCC) or melanomas.
May 31, 2022
0
2
A new study, published today in Alzheimer's & Dementia, tested whether tadalafil, a drug closely related to Viagra, may be effective in treating people with vascular dementia.
Feb 9, 2022
0
77
A test which detects changing levels of tumor fragments in the blood may be an easy, non-invasive and quick way to predict who will benefit from immunotherapy, a treatment option for advanced cancers.
Aug 3, 2020
0
158
The origins of the serious cancer-like disease Langerhans' Cell Histiocytosis (LCH) have been identified by researchers from Karolinska Institutet in collaboration with Karolinska University Hospital. The findings presented ...
Dec 16, 2022
0
52
Rady Children's Institute for Genomic Medicine (RCIGM) today announced the publication of a study in Nature Communications describing and examining the performance of Genome-to-Treatment (GTRx), an automated, virtual disease ...
Jul 26, 2022
0
5
